A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

Abroad (travel likely)RecruitingPHASE2

Conditions

Adenovirus Infection · EBV · Cytomegalovirus Infections · Cytokine Capture System · Allogenic Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Universitätsspital Basel, Basel, Switzerland
Contact: Study coordinator (Nina Khanna, Dr.) · nina.khanna@usb.ch · 0041-61-
Contact: Principal Investigator (Nina Khanna, Dr.)

Study leads

Nina Khanna, Dr.
Principal Investigator
Universitätsspital Basel, Klinik für Infektiologie

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Pathogen Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Cytomegalovirus · Adenovirus

Abroad (travel likely)RecruitingPHASE2

Memphis, United States

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Adenovirus · Cytomegalovirus Infections · Epstein-Barr Virus Infections

Abroad (travel likely)RecruitingPHASE1, PHASE2

Palo Alto, United States · Palo Alto, United States

A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

Adenovirus Infections · Cytomegalovirus Infection

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Los Angeles, United States